Great Prostate Cancer Challenge Expands to 32 Cities in 2012

WASHINGTON, Jan. 12, 2012 /PRNewswire-USNewswire/ -- The Great Prostate Cancer Challenge®, the premier men's health event series in America, managed by ZERO – The Project to End Prostate Cancer, will host events in 32 cities in 2012 to raise funds for prostate cancer research, advocacy and awareness.

(Logo: http://photos.prnewswire.com/prnh/20110225/ZEROLOGO)

"In 2012, more than 240,000 men will be diagnosed with prostate cancer and more than 28,000 will die from the disease," said Skip Lockwood, CEO of ZERO — The Project to End Prostate Cancer. "As the success of our event series continues to grow, we're better equipped to reduce these numbers by funding research, advocacy and awareness efforts."

In 2012, the event series is expanding to 32 cities including new events in Fort Lauderdale, Cleveland, Los Angeles, Shreveport and Lancaster, PA. In 2011 the GPCC series raised nearly $2 million by hosting more than 12,000 athletes in 27 cities across the nation including Atlanta, Charlotte, Dallas, Detroit and a celebrity golf tournament in Myrtle Beach, SC.

The goal of the GPCC is to end prostate cancer by building a network of local race partners across the country with a massive amount of participants in the same way that organizations like The Susan G. Komen Foundation have brought attention to breast cancer and women's health issues.

In 2007, Chesapeake Urology Associates, one of the largest urology practice groups in the nation and located in the greater Baltimore area, created an event solely focused on prostate cancer. Other urology groups across the country soon joined the successful GPCC series to create awareness and raise funds for prostate cancer research through highly successful 5K run events. In 2009, ZERO took on the GPCC as its signature awareness and fundraising program in its efforts to save lives through research and testing.  

Funds from the event series go to national and local efforts to save lives from prostate cancer. National funds help ZERO increase prostate cancer research funding from the federal government and provide free testing for high-risk men and local funds provide education and free testing in event communities.

Premier Partner Abbott and many other national and local sponsors are dedicated to ending prostate cancer and support the GPCC.

To learn more about the GPCC, visit www.greatprostatecancerchallenge.com

About ZERO — The Project to End Prostate Cancer (www.zerocancer.org)
As ZERO — The Project to End Prostate Cancer, we commit ourselves not only to reduce prostate cancer or alleviate the pain from the disease but to end it. We see a future where all men who have been diagnosed with prostate cancer will be cured or manage their illness with good quality of life, with the support they need to minimize physical and emotional suffering and to cope effectively throughout their cancer journeys.

To accomplish our goal, we increase research funds from the federal government to find new treatments and we fund local grants to end prostate cancer through our national event series, the Great Prostate Cancer Challenge. We conduct free testing through the Drive Against Prostate Cancer mobile testing program and educate patients, families and those at risk.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Skip Lockwood
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=86483

SOURCE ZERO - The Project to End Prostate Cancer

Suggested Articles

An online pharmacy has again criticized FDA action after tipping off regulators to the existence of a dangerous impurity in Zantac and other antacids.

A group of senators is asking the FTC to take a careful look at pharma mergers given the cost of drugs in the U.S.

Life’s been tough for J&J's prostate cancer med Erleada in its battle with Pfizer-Astellas’ Xtandi. A new FDA nod could help level the playing field.…